Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD

Key Inclusion Criteria: * Diagnosis of CNV secondary to AMD confirmed by fluorescein angiography, not previously treated * Retinal thickness due to edema of at least 300um in the study eye * Best corrected visual acuity of 20/80 or worse in the study eye * Best corrected visual acuity of 20/40 or better in the fellow eye Exclusion Criteria: * Evidence of scarring CNV (e.g. geographic atrophy) in the study eye * Fibrosis \>75% of lesion area in the study eye